Moreover, ABCB1 or ABCG2 overexpression in cancer cells is often associated with multidrug resistance (MDR) and poor prognosis in patients with solid tumors [6,7,8,9] or hematologic cancers [10,11,12,13,14,15,16]. The gene discussed is ABCB1; the disease is cancer.